{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:51:46Z","timestamp":1791546706594,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Special Fund of the National Clinical Key Specialty Construction Program, P.R.China"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371706"],"award-info":[{"award-number":["82371706"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071721"],"award-info":[{"award-number":["82071721"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-invasive preimplantation genetic testing for aneuploidy (niPGT-A) can detect embryo chromosomal aneuploidy by analyzing the cell-free DNA in embryo culture media. However, evidence for its clinical efficacy is insufficient. In this investigator-initiated, multicenter, double-blind, randomised controlled trial, women aged 35-42 who agreed to single frozen-thawed blastocyst transfer with at least two blastocysts were enrolled from 13 fertility centers in China. Eligible participants were randomly assigned (1:1) to the niPGT-A(\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009594) or morphology group(\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009595) using a computer-generated block randomization list, stratified by participating center. In the niPGT-A group, embryos were selected for the first transfer cycle based on niPGT-A results, whereas in the morphology group, embryos were selected according to standard morphological criteria. The primary outcome was the ongoing pregnancy rate (OPR) (pregnancy beyond 12 weeks). Secondary outcomes included clinical pregnancy, miscarriage (pregnancy loss before the 28th week, with those before the 12th week as early miscarriages), and live birth rates. The trial has been completed. The modified intention-to-treat population(mITT) contained 581 couples in the morphology group and 571 in the niPGT-A group. Among 1152 randomised patients, OPR was 38.7% (221\/571) in the niPGT-A group and 36.8% (214\/581) in the morphology group (adjusted\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.49). There were no statistically significant between group differences in the rates of clinical pregnancy (47.6% vs 49.9%, adjusted\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.49), miscarriage (21.0% vs 27.6%, adjusted\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.06) and live birth (37.0% vs 35.5%, adjusted\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.59). Early miscarriage was significantly lower in the niPGT-A group compared with that of the morphology group (18.0% vs 25.2%, adjusted\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.03). Maternal and neonatal outcomes did not differ significantly between groups. No serious adverse events were reported in either group. The results indicated that there was insufficient evidence to establish a statistically significant difference in OPR between the two treatment arms. The results of this trial do not provide a basis for recommending routine use of niPGT-A in this good-prognosis population (NCT04339166).\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-77628-4","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:03:51Z","timestamp":1788905031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Embryo selection by non-invasive preimplantation genetic testing for aneuploidy in women of advanced maternal age: a randomized, clinical trial"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1879-4219","authenticated-orcid":false,"given":"Jin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0305-5579","authenticated-orcid":false,"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3024-038X","authenticated-orcid":false,"given":"Liyi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanzi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2680-9679","authenticated-orcid":false,"given":"Yanwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6868-0861","authenticated-orcid":false,"given":"Weiping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2469-1996","authenticated-orcid":false,"given":"Sijia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-2341","authenticated-orcid":false,"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2126-1376","authenticated-orcid":false,"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"77628_CR1","doi-asserted-by":"crossref","unstructured":"Adamson, G. D. et al. O-122\u2003ICMART Preliminary World Report 2020. Hum. Reprod. 39, deae108.137 (2024).","DOI":"10.1093\/humrep\/deae108.137"},{"key":"77628_CR2","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/S0140-6736(18)32843-5","volume":"393","author":"D Wei","year":"2019","unstructured":"Wei, D. et al. Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial. Lancet 393, 1310\u20131318 (2019).","journal-title":"Lancet"},{"key":"77628_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1056\/NEJMoa1705334","volume":"378","author":"Y Shi","year":"2018","unstructured":"Shi, Y. et al. Transfer of fresh versus frozen embryos in ovulatory women. N. Engl. J. Med. 378, 126\u2013136 (2018).","journal-title":"N. Engl. J. Med."},{"key":"77628_CR4","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/humrep\/des179","volume":"27","author":"M Sugiura-Ogasawara","year":"2012","unstructured":"Sugiura-Ogasawara, M. et al. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum. Reprod. 27, 2297\u20132303 (2012).","journal-title":"Hum. Reprod."},{"key":"77628_CR5","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1093\/humrep\/del305","volume":"21","author":"EJ Margalioth","year":"2006","unstructured":"Margalioth, E. J., Ben-Chetrit, A., Gal, M. & Eldar-Geva, T. Investigation and treatment of repeated implantation failure following IVF-ET. Hum. Reprod. 21, 3036\u20133043 (2006).","journal-title":"Hum. Reprod."},{"key":"77628_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa021","volume":"2020","author":"F Carvalho","year":"2020","unstructured":"Carvalho, F. et al. ESHRE PGT Consortium good practice recommendations for the organisation of PGT. Hum. Reprod. Open 2020, hoaa021 (2020).","journal-title":"Hum. Reprod. Open"},{"key":"77628_CR7","doi-asserted-by":"crossref","unstructured":"Orvieto, R. The use of preimplantation genetic testing for aneuploidy: a committee opinion. Fertil. Steril. 122, 555 (2024).","DOI":"10.1016\/j.fertnstert.2024.05.166"},{"key":"77628_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoad010","volume":"2023","author":"F Spinella","year":"2023","unstructured":"Spinella, F. et al. ESHRE PGT Consortium data collection XXI: PGT analyses in 2018. Hum. Reprod. Open 2023, hoad010 (2023).","journal-title":"Hum. Reprod. Open"},{"key":"77628_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/AOG.0000000000004712","volume":"139","author":"BS Bedrick","year":"2022","unstructured":"Bedrick, B. S. et al. State-mandated insurance coverage and preimplantation genetic testing in the United States. Obstet. Gynecol. 139, 500\u2013508 (2022).","journal-title":"Obstet. Gynecol."},{"key":"77628_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/AOG.0000000000004737","volume":"139","author":"JL Eaton","year":"2022","unstructured":"Eaton, J. L. State-mandated in vitro fertilization coverage and utilization of preimplantation genetic testing: skewing the sex ratio. Obstet. Gynecol. 139, 498\u2013499 (2022).","journal-title":"Obstet. Gynecol."},{"key":"77628_CR11","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1056\/NEJMoa2103613","volume":"385","author":"J Yan","year":"2021","unstructured":"Yan, J. et al. Live birth with or without preimplantation genetic testing for aneuploidy. N. Engl. J. Med. 385, 2047\u20132058 (2021).","journal-title":"N. Engl. J. Med."},{"key":"77628_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-017-0251-8","volume":"15","author":"N Gleicher","year":"2017","unstructured":"Gleicher, N. et al. A single trophectoderm biopsy at blastocyst stage is mathematically unable to determine embryo ploidy accurately enough for clinical use. Reprod. Biol. Endocrinol. 15, 33 (2017).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"77628_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molmed.2020.11.009","volume":"27","author":"N Gleicher","year":"2021","unstructured":"Gleicher, N., Patrizio, P. & Brivanlou, A. Preimplantation genetic testing for aneuploidy\u2014a castle built on sand. Trends Mol. Med. 27, 731\u2013742 (2021).","journal-title":"Trends Mol. Med."},{"key":"77628_CR14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.fertnstert.2013.04.039","volume":"100","author":"RT Scott","year":"2013","unstructured":"Scott, R. T., Upham, K. M., Forman, E. J., Zhao, T. & Treff, N. R. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil. Steril. 100, 624\u2013630 (2013).","journal-title":"Fertil. Steril."},{"key":"77628_CR15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.fertnstert.2016.01.011","volume":"105","author":"S Zhang","year":"2016","unstructured":"Zhang, S. et al. Number of biopsied trophectoderm cells is likely to affect the implantation potential of blastocysts with poor trophectoderm quality. Fertil. Steril. 105, 1222\u20131227 e1224 (2016).","journal-title":"Fertil. Steril."},{"key":"77628_CR16","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1093\/humrep\/det314","volume":"28","author":"S Stigliani","year":"2013","unstructured":"Stigliani, S., Anserini, P., Venturini, P. L. & Scaruffi, P. Mitochondrial DNA content in embryo culture medium is significantly associated with human embryo fragmentation. Hum. Reprod. 28, 2652\u20132660 (2013).","journal-title":"Hum. Reprod."},{"key":"77628_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/humupd\/dmz033","volume":"26","author":"M Leaver","year":"2020","unstructured":"Leaver, M. & Wells, D. Non-invasive preimplantation genetic testing (niPGT): the next revolution in reproductive genetics? Hum. Reprod. Update 26, 16\u201342 (2020).","journal-title":"Hum. Reprod. Update"},{"key":"77628_CR18","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.fertnstert.2021.01.028","volume":"115","author":"BM Hanson","year":"2021","unstructured":"Hanson, B. M. et al. Noninvasive preimplantation genetic testing for aneuploidy exhibits high rates of deoxyribonucleic acid amplification failure and poor correlation with results obtained using trophectoderm biopsy. Fertil. Steril. 115, 1461\u20131470 (2021).","journal-title":"Fertil. Steril."},{"key":"77628_CR19","doi-asserted-by":"crossref","unstructured":"Volovsky, M., Scott, R. T., Jr. & Seli, E. Non-invasive preimplantation genetic testing for aneuploidy: is the promise real? Hum. Reprod. 39, 1899\u20131908 (2024).","DOI":"10.1093\/humrep\/deae151"},{"key":"77628_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/humrep\/dey028","volume":"33","author":"M Vera-Rodriguez","year":"2018","unstructured":"Vera-Rodriguez, M. et al. Origin and composition of cell-free DNA in spent medium from human embryo culture during preimplantation development. Hum. Reprod. 33, 745\u2013756 (2018).","journal-title":"Hum. Reprod."},{"key":"77628_CR21","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/humrep\/dez075","volume":"34","author":"J Jiao","year":"2019","unstructured":"Jiao, J. et al. Minimally invasive preimplantation genetic testing using blastocyst culture medium. Hum. Reprod. 34, 1369\u20131379 (2019).","journal-title":"Hum. Reprod."},{"key":"77628_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.fertnstert.2016.10.015","volume":"107","author":"ER Hammond","year":"2017","unstructured":"Hammond, E. R. et al. Characterizing nuclear and mitochondrial DNA in spent embryo culture media: genetic contamination identified. Fertil. Steril. 107, 220\u2013228 e225 (2017).","journal-title":"Fertil. Steril."},{"key":"77628_CR23","doi-asserted-by":"publisher","first-page":"751 e751","DOI":"10.1016\/j.ajog.2020.04.035","volume":"223","author":"C Rubio","year":"2020","unstructured":"Rubio, C. et al. Multicenter prospective study of concordance between embryonic cell-free DNA and trophectoderm biopsies from 1301 human blastocysts. Am. J. Obstet. Gynecol. 223, 751 e751\u2013751 e713 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"77628_CR24","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1093\/humrep\/deae156","volume":"39","author":"D Sakkas","year":"2024","unstructured":"Sakkas, D. et al. The impact of implementing a non-invasive preimplantation genetic testing for aneuploidies (niPGT-A) embryo culture protocol on embryo viability and clinical outcomes. Hum. Reprod. 39, 1952\u20131959 (2024).","journal-title":"Hum. Reprod."},{"key":"77628_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057254","volume":"12","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. Embryo selection through non-invasive preimplantation genetic testing with cell-free DNA in spent culture media: a protocol for a multicentre, double-blind, randomised controlled trial. BMJ Open 12, e057254 (2022).","journal-title":"BMJ Open"},{"key":"77628_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.rbmo.2022.03.006","volume":"45","author":"L Chen","year":"2022","unstructured":"Chen, L. et al. Non-invasive embryo selection strategy for clinical IVF to avoid wastage of potentially competent embryos. Reprod. Biomed. Online 45, 26\u201334 (2022).","journal-title":"Reprod. Biomed. Online"},{"key":"77628_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2024.104752","volume":"51","author":"J Huang","year":"2025","unstructured":"Huang, J. et al. Library concentration of cell-free DNA in spent culture medium: a potential indicator for clinical outcomes of blastocyst transfer. Reprod. Biomed. Online 51, 104752 (2025).","journal-title":"Reprod. Biomed. Online"},{"key":"77628_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.fertnstert.2024.02.030","volume":"122","author":"G Nakhuda","year":"2024","unstructured":"Nakhuda, G., Rodriguez, S., Tormasi, S. & Welch, C. A pilot study to investigate the clinically predictive values of copy number variations detected by next-generation sequencing of cell-free deoxyribonucleic acid in spent culture media. Fertil. Steril. 122, 42\u201351 (2024).","journal-title":"Fertil. Steril."},{"key":"77628_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.fertnstert.2019.04.038","volume":"112","author":"C Rubio","year":"2019","unstructured":"Rubio, C. et al. Embryonic cell-free DNA versus trophectoderm biopsy for aneuploidy testing: concordance rate and clinical implications. Fertil. Steril. 112, 510\u2013519 (2019).","journal-title":"Fertil. Steril."},{"key":"77628_CR30","doi-asserted-by":"crossref","unstructured":"Ardestani, G. et al. Culture time to optimize embryo cell-free DNA (cfDNA) analysis for frozen-thawed blastocysts undergoing non-invasive preimplantation genetic testing for aneuploidy (niPGT-A). Fertil. Steril. 122, 465\u2013473 (2024).","DOI":"10.1016\/j.fertnstert.2024.04.037"},{"key":"77628_CR31","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. DNA methylome reveals cellular origin of cell-free DNA in spent medium of human preimplantation embryos. J. Clin. Investig. 131, e146051 (2021).","DOI":"10.1172\/JCI146051"},{"key":"77628_CR32","doi-asserted-by":"crossref","unstructured":"Bakalova, D. N., Navarro-S\u00e1nchez, L. & Rubio, C. Non-invasive preimplantation genetic testing. Genes 16, 552 (2025).","DOI":"10.3390\/genes16050552"},{"key":"77628_CR33","doi-asserted-by":"crossref","unstructured":"Huang, J. et al. Chromosome screening of human preimplantation embryos by using spent culture medium: sample collection and chromosomal ploidy analysis. J. Vis. Exp. 175, e62619 (2021).","DOI":"10.3791\/62619"},{"key":"77628_CR34","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1093\/humrep\/dez229","volume":"34","author":"T Sato","year":"2019","unstructured":"Sato, T. et al. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure. Hum. Reprod. 34, 2340\u20132348 (2019).","journal-title":"Hum. Reprod."},{"key":"77628_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.fertnstert.2023.02.036","volume":"120","author":"A Vitagliano","year":"2023","unstructured":"Vitagliano, A., Paffoni, A. & Vigan\u00f2, P. Does maternal age affect assisted reproduction technology success rates after euploid embryo transfer? A systematic review and meta-analysis. Fertil. Steril. 120, 251\u2013265 (2023).","journal-title":"Fertil. Steril."},{"key":"77628_CR36","unstructured":"Gardner, D. K. & Schoolcraft, W. B. In vitro culture of human blastocyst. In Toward Reproductive Certainty: Infertility and Genetics Beyond (eds Jansen, R. & Mortimer, D.) 378\u2013388 (Parthenon Press, 1999)."},{"key":"77628_CR37","doi-asserted-by":"publisher","first-page":"11907","DOI":"10.1073\/pnas.1613294113","volume":"113","author":"J Xu","year":"2016","unstructured":"Xu, J. et al. Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization. Proc. Natl. Acad. Sci. USA 113, 11907\u201311912 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77628-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77628-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77628-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:02:44Z","timestamp":1791543764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77628-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77628"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77628-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests. J.H. reports research funding from the National Key Research and Development Program of China (2023YFC2705604 and 2018YFC1003100) and the National Science Foundation of China (82371706 and 82071721) during the conduct of the study. J.Q. reports research funding from the special fund of the National Clinical Key Specialty Construction Program, P.R. China (2023) during the conduct of the study. J.W., Y.X.Y., and S.J.L. are affiliated with Yikon Genomics Co., Ltd., where S.J.L. serves as the Chief Executive Officer. Y.X.Y. and S.J.L. hold equity interests in the company. The remaining authors report no competing interests. Yikon Genomics Co., Ltd. provided NICS testing services for this study.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10634"}}